163 related articles for article (PubMed ID: 7567146)
21. Meningitis caused by a penicillin- and chloramphenicol-resistant Streptococcus pneumoniae.
Collignon PJ; Bell J; Hufton IW; Mitchell D
Med J Aust; 1988 Nov; 149(9):497-8. PubMed ID: 3185344
[TBL] [Abstract][Full Text] [Related]
22. The impact of blood cultures on antibiotic therapy in pneumococcal pneumonia.
Waterer GW; Jennings SG; Wunderink RG
Chest; 1999 Nov; 116(5):1278-81. PubMed ID: 10559087
[TBL] [Abstract][Full Text] [Related]
23. Appearance of resistance to beta-lactam antibiotics during therapy for Streptococcus pneumoniae meningitis.
Muñoz M; Valderrabanos ES; Diaz E; Silva JJ; Soult JA; Infante P; Lopez JD; Garcia-Curiel A
J Pediatr; 1995 Jul; 127(1):98-9. PubMed ID: 7608819
[TBL] [Abstract][Full Text] [Related]
24. Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review.
John CC
Clin Infect Dis; 1994 Feb; 18(2):188-93. PubMed ID: 8161625
[TBL] [Abstract][Full Text] [Related]
25. Vancomycin Should Be Part of Empiric Therapy for Suspected Bacterial Meningitis.
Olarte L
J Pediatric Infect Dis Soc; 2019 May; 8(2):187-188. PubMed ID: 30496558
[TBL] [Abstract][Full Text] [Related]
26. Acute bacterial meningitis caused by Streptococcus pneumoniae resistant to the antimicrobian agents and their serotypes.
Rossoni AM; Dalla Costa LM; Berto DB; Farah SS; Gelain M; Brandileone MC; Ramos VH; Almeida SM
Arq Neuropsiquiatr; 2008 Sep; 66(3A):509-15. PubMed ID: 18813710
[TBL] [Abstract][Full Text] [Related]
27. Failure of cefotaxime treatment in an adult with Streptococcus pneumoniae meningitis.
Pacheco TR; Cooper CK; Hardy DJ; Betts RF; Bonnez W
Am J Med; 1997 Mar; 102(3):303-5. PubMed ID: 9217602
[No Abstract] [Full Text] [Related]
28. Relapsing pneumococcal meningitis: isolation of an organism with decreased susceptibility to penicillin G.
Naraqi S; Kirkpatrick GP; Kabins S
J Pediatr; 1974 Nov; 85(5):671-3. PubMed ID: 4153968
[No Abstract] [Full Text] [Related]
29. [Pneumococcal meningitis in children: should probabilistic antibiotherapy of infectious meningitis be modified?].
Le Masne A; Gaillard JL; Lacaille F; Pron B; Labenne M; Silly C; Chéron G
Arch Pediatr; 1996 May; 3(5):419-26. PubMed ID: 8763710
[TBL] [Abstract][Full Text] [Related]
30. Outcome of penicillin-nonsusceptible Streptococcus pneumoniae meningitis: a nested case-control study.
Kellner JD; Scheifele DW; Halperin SA; Lebel MH; Moore D; Le Saux N; Ford-Jones EL; Law B; Vaudry W;
Pediatr Infect Dis J; 2002 Oct; 21(10):903-10. PubMed ID: 12394810
[TBL] [Abstract][Full Text] [Related]
31. The growing threat of antibiotic-resistant Streptococcus pneumoniae.
Lonks JR; Medeiros AA
Med Clin North Am; 1995 May; 79(3):523-35. PubMed ID: 7752726
[TBL] [Abstract][Full Text] [Related]
32. Prolonged pneumococcal meningitis due to an organism with increased resistance to penicillin.
Paredes A; Taber LH; Yow MD; Clark D; Nathan W
Pediatrics; 1976 Sep; 58(3):378-81. PubMed ID: 8756
[TBL] [Abstract][Full Text] [Related]
33. Drug-resistant Streptococcus pneumoniae: the beginning of the end for many antibiotics? Australian Group on Antimicrobial Resistance (AGAR).
Collignon PJ; Bell JM
Med J Aust; 1996 Jan; 164(2):64-7. PubMed ID: 8569573
[TBL] [Abstract][Full Text] [Related]
34. Mortality indicators in pneumococcal meningitis: therapeutic implications.
Erdem H; Elaldi N; Öztoprak N; Sengoz G; Ak O; Kaya S; Inan A; Nayman-Alpat S; Ulu-Kilic A; Pekok AU; Gunduz A; Gozel MG; Pehlivanoglu F; Yasar K; Yılmaz H; Hatipoglu M; Cicek-Senturk G; Akcam FZ; Inkaya AC; Kazak E; Sagmak-Tartar A; Tekin R; Ozturk-Engin D; Ersoy Y; Sipahi OR; Guven T; Tuncer-Ertem G; Alabay S; Akbulut A; Balkan II; Oncul O; Cetin B; Dayan S; Ersoz G; Karakas A; Ozgunes N; Sener A; Yesilkaya A; Erturk A; Gundes S; Karabay O; Sirmatel F; Tosun S; Turhan V; Yalci A; Akkoyunlu Y; Aydın E; Diktas H; Kose S; Ulcay A; Seyman D; Savasci U; Leblebicioglu H; Vahaboglu H
Int J Infect Dis; 2014 Feb; 19():13-9. PubMed ID: 24211227
[TBL] [Abstract][Full Text] [Related]
35. [Therapeutic failure with high-dose cefotaxime in pneumococcal meningitis].
Michaus ML; Pérez-Díaz L; de Pablos M; Lezaun MJ; López-Bayón J
Enferm Infecc Microbiol Clin; 1997 May; 15(5):276-7. PubMed ID: 9376392
[No Abstract] [Full Text] [Related]
36. [Ceftriaxone-resistant Streptococcus pneumoniae meningitis: case report].
Saavedra-Velasco M; Tapia-Cruz M; Grandez-Urbina JA; Zegarra Del Rosario-Alvarado S; Mendo-Urbina F; Pichardo-Rodriguez R
Rev Peru Med Exp Salud Publica; 2019; 36(2):349-352. PubMed ID: 31460651
[TBL] [Abstract][Full Text] [Related]
37. Mortality in penicillin-resistant pneumococcal meningitis.
Klugman KP; Walsh AL; Phiri A; Molyneux EM
Pediatr Infect Dis J; 2008 Jul; 27(7):671-2. PubMed ID: 18520964
[No Abstract] [Full Text] [Related]
38. Bacteriologic outcome of children with cefotaxime- or ceftriaxone-susceptible and -nonsusceptible Streptococcus pneumoniae meningitis.
Olivier C; Cohen R; Begué P; Floret D
Pediatr Infect Dis J; 2000 Oct; 19(10):1015-7. PubMed ID: 11055609
[No Abstract] [Full Text] [Related]
39. Impredictable susceptibility for cephalosporins in penicillin resistant Streptococcus pneumoniae.
Verhaegen J; Vandeven J; Verbiest N; Fossion M; Mengeot PM; Amougou M; Verbist L
Acta Clin Belg; 1997; 52(2):116-7. PubMed ID: 9204588
[No Abstract] [Full Text] [Related]
40. Penicillin- and Cephalosporin-Resistant Pneumococcal Meningitis: Treatment in the Real World and in Guidelines.
Cabellos C; Guillem L; Pelegrin I; Tubau F; Ardanuy C; Gudiol F; Ariza J; Viladrich PF
Antimicrob Agents Chemother; 2022 Dec; 66(12):e0082022. PubMed ID: 36326246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
